|
||
Original Article |
katsura{at}frontier.kyoto-u.ac.jp
We have established a new clonal assay system that can evenly support the development of T and natural killer (NK) cells. With this system, we show that all T cell progenitors in the earliest CD44+CD25–Fc
RII/III– fetal thymus (FT) cell population retain NK potential, and that the NK lineage–committed progenitors (p-NK) also exist in this population. T cell lineage–committed progenitors (p-T), which are unable to generate NK cells, first appear at the CD44+CD25– Fc
RII/III+ stage in day 12 FT. The proportion of p-T markedly increases during the transition from the CD44+CD25– stage to the CD44+CD25+ stage in day 14 FT. On the other hand, p-NK preferentially increase in number at the CD44+CD25– stage between days 12 and 14 of gestation. The production of p-NK continues up to the CD44+CD25+ stage, but ceases before the rearrangement of T cell receptor β chain genes. It was further shown that the CD44+CD25– CD122+ population of day 14 FT exclusively contains p-NK. These results indicate that the earliest T cell progenitor migrating into the FT is T/NK bipotent, and strongly suggest that the bipotent progenitor continuously produces p-NK and p-T until the CD44+CD25+ stage.
Key Words: T cell natural killer cell hematopoietic stem cell thymus clonal assay
RII/III; FL, fetal liver; FT, fetal thymus; HOS, high oxygen submersion; Lin, lineage marker; MLP, multilineage progenitor; p-NK, NK lineage–committed progenitor; p-T, T cell lineage–committed progenitor; p-T/NK, bipotent progenitor generating T and NK cells; SCF, stem cell factor. © 1999 The Rockefeller University Press
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| TABLE OF CONTENTS |
|